These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 31596958)
1. Trends in the overall survival rates in women with advanced ovarian cancer in a single tertiary centre in New Zealand. Yeoh S; Simcock B; Innes C; Mclachlan J; Harker D; Sykes P Aust N Z J Obstet Gynaecol; 2019 Dec; 59(6):861-866. PubMed ID: 31596958 [TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer: patterns of care in Victoria during 1993-1995. Grossi M; Quinn MA; Thursfield VJ; Francis PA; Rome RM; Planner RS; Giles GG Med J Aust; 2002 Jul; 177(1):11-6. PubMed ID: 12088472 [TBL] [Abstract][Full Text] [Related]
4. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study. Seagle BL; Graves S; Strohl AE; Shahabi S Int J Gynecol Cancer; 2017 Oct; 27(8):1610-1618. PubMed ID: 28763362 [TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Survival of Patients with Malignant Ovarian Tumors in Addis Ababa, Ethiopia. Piszczan S; Desalegn D; Petros H; Gurmu M; Kroeber ES; Addissie A; Mikolajczyk R; Ghebre RG; Mathewos A; Thomssen C; Jemal A; Kantelhardt EJ Oncologist; 2019 Jun; 24(6):e303-e311. PubMed ID: 31023861 [TBL] [Abstract][Full Text] [Related]
6. Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study. Dahm-Kähler P; Palmqvist C; Staf C; Holmberg E; Johannesson L Gynecol Oncol; 2016 Aug; 142(2):211-6. PubMed ID: 27238084 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. May T; Comeau R; Sun P; Kotsopoulos J; Narod SA; Rosen B; Ghatage P Int J Gynecol Cancer; 2017 May; 27(4):668-674. PubMed ID: 28441250 [TBL] [Abstract][Full Text] [Related]
8. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey. Fagö-Olsen CL; Høgdall C; Kehlet H; Christensen IJ; Ottesen B Acta Obstet Gynecol Scand; 2011 Mar; 90(3):273-9. PubMed ID: 21306310 [TBL] [Abstract][Full Text] [Related]
9. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data. Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852 [TBL] [Abstract][Full Text] [Related]
10. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710 [TBL] [Abstract][Full Text] [Related]
11. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands. van Altena AM; Karim-Kos HE; de Vries E; Kruitwagen RF; Massuger LF; Kiemeney LA Gynecol Oncol; 2012 Jun; 125(3):649-54. PubMed ID: 22370602 [TBL] [Abstract][Full Text] [Related]
12. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study. Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976 [TBL] [Abstract][Full Text] [Related]
13. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990. Venesmaa P Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis. Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer. Gockley A; Melamed A; Cronin A; Bookman MA; Burger RA; Cristae MC; Griggs JJ; Mantia-Smaldone G; Matulonis UA; Meyer LA; Niland J; O'Malley DM; Wright AA Am J Obstet Gynecol; 2019 Dec; 221(6):625.e1-625.e14. PubMed ID: 31207237 [TBL] [Abstract][Full Text] [Related]
16. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer. Rosen B; Laframboise S; Ferguson S; Dodge J; Bernardini M; Murphy J; Segev Y; Sun P; Narod SA Gynecol Oncol; 2014 Sep; 134(3):462-7. PubMed ID: 25026637 [TBL] [Abstract][Full Text] [Related]
17. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy. Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918 [TBL] [Abstract][Full Text] [Related]
18. Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study. Warren JL; Harlan LC; Trimble EL; Stevens J; Grimes M; Cronin KA Gynecol Oncol; 2017 Jun; 145(3):486-492. PubMed ID: 28372872 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience. Chung YS; Lee JY; Kim HS; Nam EJ; Kim SW; Kim YT Yonsei Med J; 2018 Oct; 59(8):930-936. PubMed ID: 30187699 [TBL] [Abstract][Full Text] [Related]
20. No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands. Timmermans M; Sonke GS; Van de Vijver KK; van der Aa MA; Kruitwagen RFPM Eur J Cancer; 2018 Jan; 88():31-37. PubMed ID: 29179135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]